Inotropic effects of prostaglandin E2 on isolated cardiac tissue.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006325:Heart Atria; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009206:Myocardium; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical; D013618:Tachyphylaxis
D001949:Bretylium Compounds; D011453:Prostaglandins; D010643:Phenoxybenzamine; D001285:Atropine; D012110:Reserpine; D004155:Diphenhydramine; D011433:Propranolol